For more than 50 years, we’ve been at the forefront of cattle vaccination, playing a crucial leadership role in the advancement of vaccine science and technology, and helping to pave the way for healthier herds.
We’re proud of the breakthroughs we’ve achieved (and those still to come), and of the cutting-edge cattle vaccines – many of which were industry firsts – that we’ve developed over the years to meet the changing needs of producers and veterinarians.
Join us on a trip down “innovation lane”
In their own words
Our ongoing legacy of vaccine innovation
Spotlight on three standouts in our BOVILIS® cattle vaccine portfolio
Vision® 8 Somnus with SPUR®
Dual clostridial and Histophilus somni (Haemophilus somnus) coverage in a unique low-volume 2-mL vaccine with advanced antigen delivery.
The first and only scours vaccine labeled for subcutaneous administration.
Bovilis® Nasalgen® 3-PMH
The first and only 5-way intranasal vaccine that helps protect against both viral and bacterial bovine respiratory disease (BRD) pathogens, with a single dose.
Always read and follow the label instructions to ensure the product is suitable for the animal to be vaccinated.
Vaccination may not protect every animal that gets vaccinated.
BOVILIS®, GUARDIAN®, SPUR® and VISION® are registered trademarks of Intervet International B.V. Used under license.
NASALGEN® is a registered trademark of Intervet Inc. Used under license.
MERCK® is a registered trademark of Merck Sharp & Dohme LLC. Used under license.
© 2023 Merck & Co., Inc., Rahway, NJ, USA and its affiliates. All rights reserved.